Viewing nowElcarina Tablet (L-Carnitine)
L-Carnitine 330mg
Tablet · OTC medication
SS Pharm Co., Ltd.

MFDS item code 200810951 · Notified 2008.11.12
Improvement of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease
This medication helps improve symptoms of carnitine deficiency in patients with primary and secondary carnitine deficiency by supplementing carnitine. It is also used to treat myocardial metabolic disorders caused by ischemic heart disease, such as angina or acute myocardial infarction, aiding in heart function recovery and metabolic disorder improvement.
Adults: Administer 2-3g of L-carnitine orally per day in 2-3 divided doses. The dose may be adjusted according to age and symptoms.
This medication should not be used by patients with an allergy to this drug or those with a history of hypersensitivity or allergy to soybean oil, soy, peanuts, etc. Patients with conditions such as disturbed fat metabolism, hyperlipoproteinemia, diabetic dyslipidemia, or pancreatitis should use this drug with caution. Temporary side effects such as nausea, vomiting, abdominal pain, diarrhea, and changes in body odor may occur upon taking this medication. Allergic symptoms such as skin rash, hives, and facial swelling may also occur. Some patients with impaired renal function have reported symptoms of muscle weakness, so caution is needed. For patients at risk of fat overload, blood lipid levels should be checked before and during treatment with this medication, and if fat excretion is inadequate, the dosage of the drug should be adjusted. Additionally, when using intravenous medications that contain other lipid components, the dosage of those medications must be reduced considering the lipid components in this medication. Pregnant women or women who may become pregnant should only use this medication when the benefits of treatment outweigh the risks, as the safety of this drug has not been fully confirmed during pregnancy. Women who are breastfeeding should also exercise caution as this medication may be passed into breast milk.
Not everyone experiences these, and they can vary from person to person.
Consult a doctor or pharmacist when using this medication in conjunction with intravenous lipid preparations.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to keep it at room temperature, between 1 to 30 degrees Celsius.
White, round, film-coated tablet
90 tablets (10 tablets/PTP x 9)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowL-Carnitine 330mg
Tablet · OTC medication
SS Pharm Co., Ltd.
L-Carnitine 200mg
Prescription medication
Albozen Korea Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Seoul Pharmaceutical Co., Ltd.
L-Carnitine 330mg
Tablet · OTC medication
HLB Pharmaceuticals Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Daehan New Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Mothers Pharmaceuticals Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Hubist Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.